↓ Skip to main content

PLOS

Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study

Overview of attention for article published in PLOS ONE, October 2013
Altmetric Badge

Mentioned by

twitter
4 X users
patent
1 patent
facebook
1 Facebook page
googleplus
1 Google+ user
f1000
1 research highlight platform

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
161 Mendeley
Title
Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study
Published in
PLOS ONE, October 2013
DOI 10.1371/journal.pone.0078111
Pubmed ID
Authors

Julio Plaza-Diaz, Carolina Gomez-Llorente, Laura Campaña-Martin, Esther Matencio, Inmaculada Ortuño, Rosario Martínez-Silla, Carlos Gomez-Gallego, Maria Jesús Periago, Gaspar Ros, Empar Chenoll, Salvador Genovés, Beatriz Casinos, Ángela Silva, Dolores Corella, Olga Portolés, Fernando Romero, Daniel Ramón, Antonio Perez de la Cruz, Angel Gil, Luis Fontana

Abstract

We previously described the isolation and characterization of three probiotic strains from the feces of exclusively breast-fed newborn infants: Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036. These strains were shown to adhere to intestinal mucus in vitro, to be sensitive to antibiotics and to resist biliary salts and low pH. In the present study, a multicenter, randomized, double-blind, placebo-controlled trial with 100 healthy volunteers in three Spanish cities was carried out to evaluate the tolerance, safety, gut colonization and immunomodulatory effects of these three probiotics. Volunteers underwent a 15-day washout period, after which they were randomly divided into 5 groups that received daily a placebo, a capsule containing one of the 3 strains or a capsule containing a mixture of two strains for 30 days. The intervention was followed by another 15-day washout period. Patients did not consume fermented milk for the entire duration of the study. Gastrointestinal symptoms, defecation frequency and stool consistency were not altered by probiotic intake. No relevant changes in blood and serum, as well as no adverse events occurred during or after treatment. Probiotic administration slightly modified bacterial populations in the volunteers' feces. Intestinal persistence occurred in volunteers who received L. rhamnosus CNCM I-4036. Administration of B. breve CNCM I-4035 resulted in a significant increase in fecal secretory IgA content. IL-4 and IL-10 increased, whereas IL-12 decreased in the serum of volunteers treated with any of the three strains. These results demonstrate that the consumption of these three bacterial strains was safe and exerted varying degrees of immunomodulatory effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 1%
Unknown 159 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 13%
Student > Bachelor 21 13%
Student > Master 15 9%
Student > Ph. D. Student 12 7%
Other 10 6%
Other 37 23%
Unknown 45 28%
Readers by discipline Count As %
Medicine and Dentistry 35 22%
Agricultural and Biological Sciences 21 13%
Nursing and Health Professions 14 9%
Biochemistry, Genetics and Molecular Biology 12 7%
Immunology and Microbiology 12 7%
Other 18 11%
Unknown 49 30%